Transition zone-based prostate-specific antigen density for differentiating clinically significant prostate cancer in PI-RADS score 3 lesions

Abstract We intended to investigate the potential of several transitional zone (TZ) volume-related variables for the detection of clinically significant prostate cancer (csPCa) among lesions scored as Prostate Imaging Reporting and Data System (PI-RADS) category 3. Between September 2018 and August...

Full description

Saved in:
Bibliographic Details
Main Authors: Yongming Jin, Fei Chen, Gang Xu, Chaogang Wei, Congsong Dong
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-87311-1
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832585830760185856
author Yongming Jin
Fei Chen
Gang Xu
Chaogang Wei
Congsong Dong
author_facet Yongming Jin
Fei Chen
Gang Xu
Chaogang Wei
Congsong Dong
author_sort Yongming Jin
collection DOAJ
description Abstract We intended to investigate the potential of several transitional zone (TZ) volume-related variables for the detection of clinically significant prostate cancer (csPCa) among lesions scored as Prostate Imaging Reporting and Data System (PI-RADS) category 3. Between September 2018 and August 2023, patients who underwent mpMRI examination and scored as PI-RADS 3 were queried from our institution. The diagnostic performances of prostate-specific antigen density (PSAD), TZ-adjusted PSAD (TZPSAD), and TZ-ratio (TZ volume/whole gland prostate volume) were analyzed. We calculated the sensitivity and specificity for each variable, the overall accuracy was evaluated with the area under the receiver operating characteristic curve (AUC). The best cutoff value was determined by the Youden index, and differences between diagnostic performances were compared with the Delong test. A total of 154 TZ lesions were included, of them 28 were diagnosed with csPCa. The AUC for PSAD, TZPSAD, and TZ-ratio were 0.644 (95% CI 0.538–0.751), 0.714 (95% CI 0.607–0.821), and 0.746 (95% CI 0.636–0.856), with corresponding optimal cutoff values of 0.11 ng/ml/ml, 0.21 ng/ml/ml, and 0.66 ng/ml/ml, respectively. PSAD was significantly inferior to either TZPSAD (P = 0.03) or TZ-ratio (P = 0.03). The combination model including TZPSAD, TZ-ratio, and age generated an AUC of 0.838 (95% CI 0.759–0.917), significantly higher than use of these variables alone, with P values of 0.001 and 0.035 for the TZPSAD and TZ-ratio, respectively. TZPSAD and TZ-ratio were found to be independent predictors for differentiating csPCa among TZ lesions categorized as PI-RADS score 3. Furthermore, by combining these two variables with others, the diagnostic performance can be improved significantly.
format Article
id doaj-art-1eaa4eb9767b4055822d788448f370fa
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-1eaa4eb9767b4055822d788448f370fa2025-01-26T12:25:03ZengNature PortfolioScientific Reports2045-23222025-01-011511810.1038/s41598-025-87311-1Transition zone-based prostate-specific antigen density for differentiating clinically significant prostate cancer in PI-RADS score 3 lesionsYongming Jin0Fei Chen1Gang Xu2Chaogang Wei3Congsong Dong4Department of Radiology, The Yancheng School of Clinical Medicine of Nanjing Medical University, Yancheng Third People’s HospitalDepartment of Radiology, The Yancheng School of Clinical Medicine of Nanjing Medical University, Yancheng Third People’s HospitalDepartment of Radiology, The Yancheng School of Clinical Medicine of Nanjing Medical University, Yancheng Third People’s HospitalDepartment of Radiology, Second Affiliated Hospital of Soochow UniversityDepartment of Radiology, The Yancheng School of Clinical Medicine of Nanjing Medical University, Yancheng Third People’s HospitalAbstract We intended to investigate the potential of several transitional zone (TZ) volume-related variables for the detection of clinically significant prostate cancer (csPCa) among lesions scored as Prostate Imaging Reporting and Data System (PI-RADS) category 3. Between September 2018 and August 2023, patients who underwent mpMRI examination and scored as PI-RADS 3 were queried from our institution. The diagnostic performances of prostate-specific antigen density (PSAD), TZ-adjusted PSAD (TZPSAD), and TZ-ratio (TZ volume/whole gland prostate volume) were analyzed. We calculated the sensitivity and specificity for each variable, the overall accuracy was evaluated with the area under the receiver operating characteristic curve (AUC). The best cutoff value was determined by the Youden index, and differences between diagnostic performances were compared with the Delong test. A total of 154 TZ lesions were included, of them 28 were diagnosed with csPCa. The AUC for PSAD, TZPSAD, and TZ-ratio were 0.644 (95% CI 0.538–0.751), 0.714 (95% CI 0.607–0.821), and 0.746 (95% CI 0.636–0.856), with corresponding optimal cutoff values of 0.11 ng/ml/ml, 0.21 ng/ml/ml, and 0.66 ng/ml/ml, respectively. PSAD was significantly inferior to either TZPSAD (P = 0.03) or TZ-ratio (P = 0.03). The combination model including TZPSAD, TZ-ratio, and age generated an AUC of 0.838 (95% CI 0.759–0.917), significantly higher than use of these variables alone, with P values of 0.001 and 0.035 for the TZPSAD and TZ-ratio, respectively. TZPSAD and TZ-ratio were found to be independent predictors for differentiating csPCa among TZ lesions categorized as PI-RADS score 3. Furthermore, by combining these two variables with others, the diagnostic performance can be improved significantly.https://doi.org/10.1038/s41598-025-87311-1Prostate cancerDiagnosticPI-RADS
spellingShingle Yongming Jin
Fei Chen
Gang Xu
Chaogang Wei
Congsong Dong
Transition zone-based prostate-specific antigen density for differentiating clinically significant prostate cancer in PI-RADS score 3 lesions
Scientific Reports
Prostate cancer
Diagnostic
PI-RADS
title Transition zone-based prostate-specific antigen density for differentiating clinically significant prostate cancer in PI-RADS score 3 lesions
title_full Transition zone-based prostate-specific antigen density for differentiating clinically significant prostate cancer in PI-RADS score 3 lesions
title_fullStr Transition zone-based prostate-specific antigen density for differentiating clinically significant prostate cancer in PI-RADS score 3 lesions
title_full_unstemmed Transition zone-based prostate-specific antigen density for differentiating clinically significant prostate cancer in PI-RADS score 3 lesions
title_short Transition zone-based prostate-specific antigen density for differentiating clinically significant prostate cancer in PI-RADS score 3 lesions
title_sort transition zone based prostate specific antigen density for differentiating clinically significant prostate cancer in pi rads score 3 lesions
topic Prostate cancer
Diagnostic
PI-RADS
url https://doi.org/10.1038/s41598-025-87311-1
work_keys_str_mv AT yongmingjin transitionzonebasedprostatespecificantigendensityfordifferentiatingclinicallysignificantprostatecancerinpiradsscore3lesions
AT feichen transitionzonebasedprostatespecificantigendensityfordifferentiatingclinicallysignificantprostatecancerinpiradsscore3lesions
AT gangxu transitionzonebasedprostatespecificantigendensityfordifferentiatingclinicallysignificantprostatecancerinpiradsscore3lesions
AT chaogangwei transitionzonebasedprostatespecificantigendensityfordifferentiatingclinicallysignificantprostatecancerinpiradsscore3lesions
AT congsongdong transitionzonebasedprostatespecificantigendensityfordifferentiatingclinicallysignificantprostatecancerinpiradsscore3lesions